Showing results (71-80 of 132) with videos related to

Sort By:
Pageof 14
Phytochemistry|June 18, 2003
Identification of potent inhibitors of Helicoverpa armigera gut proteinases from winged bean seedsAshok P Giri, Abhay M Harsulkar, Maurice S B Ku, et al.
Contemporary Clinical Trials|July 9, 2017
Design and approach of the Living Organ Video Educated Donors (LOVED) program to promote living kidney donation in African AmericansJohn C Sieverdes, Matthew Price, Kenneth J Ruggiero, et al.
American Journal of Nephrology|June 28, 2014
Significant racial differences in the key factors associated with early graft loss in kidney transplant recipientsDavid J Taber, Kevin Douglass, Titte Srinivas, et al.
Journal of Family Medicine and Primary Care|December 11, 2023
Coronavirus infection and ABO blood grouping: Correlation or coincidence?Awale R Bhalchandra, Om P Sanjeev, Rajendra Chaudhary, et al.
Biochemical Pharmacology|September 23, 2009
2-(3,4-Dihydro-2H-pyrrolium-1-yl)-3oxoindan-1-olate (DHPO), a novel, synthetic small molecule that alleviates insulin resistance and lipid abnormalitiesMachender R Kandadi, Prabhakar K Rajanna, Mazhuvancherry K Unnikrishnan, et al.
Transplantation|January 17, 2015
Inclusion of dynamic clinical data improves the predictive performance of a 30-day readmission risk model in kidney transplantationDavid J Taber, Arun P Palanisamy, Titte R Srinivas, et al.
Psychiatry Research|December 6, 2003
Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patientsPrabhakar K Ranjekar, Ashwini Hinge, Mahabaleshwar V Hegde, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2004
5-Amidinobenzo[b]thiophenes as dual inhibitors of factors IXa and XaJennifer X Qiao, Xuhong Cheng, Dilip P Modi, et al.
Hypertension (Dallas, Tex. : 1979)|July 13, 2016
Impact of Cardiovascular Risk Factors on Graft Outcome Disparities in Black Kidney Transplant RecipientsDavid J Taber, Kelly J Hunt, Cory E Fominaya, et al.
Diabetes & Metabolic Syndrome|December 3, 2014
Circulatory adipocytokines and lipid profile variations in type-2 diabetic subjects: desirable side-effects of antidiabetic drugsAbhijit A Ghadge, Shubhangi M Harke, Suresh P Khadke, et al.
Pageof 14